Developer docs
API playgroundTry for free, no card

Search company profiles

Grundium

Full company profile

uuid0003jie

Namestring
Grundium
Legal namestring
Grundium Oy
Websiteurl
grundium.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Grundium Oy is a Finnish medical technology company founded in 2015 in Tampere by former Nokia engineers, specializing in compact digital pathology microscope slide scanners marketed under the Ocus brand. The product line comprises the Ocus 20 (high-speed 20x scanning for intraoperative frozen sections), Ocus 40 (high-resolution 40x imaging for cytology and research), and the Ocus M Series (four-slide capacity for higher-volume labs). All scanners deliver browser-based access without additional software, support DICOM and SMB/HTTP export, and integrate with cloud platform services for remote consultation and telepathology workflows. The Ocus devices are CE-marked under the EU In Vitro Diagnostic Regulation (IVDR, EU 2017/746) for clinical/diagnostic use in Europe, while remaining classified as Research Use Only (RUO) in the United States.

In May 2026, Grundium acquired Denmark-based Visiopharm A/S, adding nine IVDR-cleared AI diagnostic algorithms and over 750 customer accounts across more than 40 countries, transforming the company from a hardware scanner vendor into an integrated precision pathology platform combining imaging hardware with AI-powered image analysis. The combined business serves diagnostic laboratories and hospitals, biopharmaceutical research and development organizations, academic and research institutions, and — through partnerships with Zoetis and Techcyte — the veterinary pathology vertical. Revenue mechanics mix one-time hardware sales of Ocus scanners with recurring cloud platform subscriptions and, post-Visiopharm, enterprise AI software subscriptions. Distribution combines direct enterprise field sales with a global distributor network including Fisher Healthcare (exclusive US distributor) and partners in Brazil, Turkey, Korea, India, Poland, and Greece. The company is privately held and backed by EW Healthcare Partners, a specialized healthcare investment firm.

Short descriptiontext

Grundium Oy is a Finnish medical technology company that develops the Ocus line of compact digital pathology slide scanners and, following its May 2026 Visiopharm acquisition, an integrated AI-powered precision pathology platform serving diagnostic laboratories, biopharma research, academic institutions, and veterinary clinics across 40+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTampere, Finland
HQ citystring
Tampere
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology scanners, microscope slide imaging, whole slide imaging, telepathology solutions, AI precision pathology
Industry3 codes
PRIMARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Laboratory Analytical Instruments3826
  • Optical Instruments & Lenses3827
Product category
Digital Pathology Imaging Systems
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales - Ocus Scanners
TypeOne Time License
Description

Sale of physical microscope slide scanner devices including Ocus 20, Ocus 40, and Ocus M Series. One-time capital purchase model for laboratory and clinical equipment.

grundium.com
2Cloud Platform & Software Subscriptions
TypeSubscription Recurring
Description

Ongoing cloud connectivity and software platform services for scanner management, remote access, data storage, and team collaboration through grundium.net cloud infrastructure.

grundium.com
3Enterprise Platform Solutions (Post-Visiopharm)
TypeSubscription Recurring
Description

Integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications for diagnostic laboratories, biopharmaceutical development, and research organizations.

irw-press.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Quote-based enterprise sales - no public pricing available
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing tiers listed. Sales process involves direct engagement via book-a-demo and get-a-quote forms. Pricing discussed during personalized 30-minute online demo sessions.

grundium.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Ocus®
Description

Ocus® is Grundium's product line of microscope slide scanners for digital pathology, including Ocus® 20, Ocus® 40, and Ocus® M series models.

grundium.com
+3 more records
Core offering1 text field

Grundium designs, manufactures, and sells the Ocus line of compact digital pathology microscope slide scanners (Ocus 20, Ocus 40, Ocus M Series) that convert glass slides into high-resolution whole-slide images accessible through any web browser. The company complements the hardware with a cloud platform for remote collaboration and, following the May 2026 acquisition of Visiopharm, AI-powered precision pathology image analysis software with nine IVDR-cleared diagnostic algorithms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduced diagnostic turnaround time from days/weeks to minutes in veterinary telepathology applications
+3 more records
Product overview1 text field

Grundium offers the Ocus line of compact digital pathology microscope slide scanners, consisting of three scanner models: Ocus 20 (high-speed 20x scanning for frozen sections and routine histology), Ocus 40 (high-resolution 40x scanning for detailed cytology and research), and Ocus M Series (four-slide capacity multi-slide scanner for high-throughput labs). The scanners feature browser-based interfaces, onboard processing, and cloud connectivity through Grundium Cloud for remote access and collaboration. The product line recently expanded through the acquisition of Visiopharm, adding AI-powered precision pathology software with nine IVDR-cleared diagnostic algorithms for automated image analysis, creating an integrated end-to-end platform combining digital slide scanning with AI-powered diagnostic applications for diagnostic laboratories, biopharmaceutical research, and clinical applications.

Product and service4 records
1Ocus 20
CategoryMicroscope Slide Scanner
Description

High-speed digital microscope slide scanner optimized for 20x magnification, intended for time-sensitive procedures such as intraoperative frozen sections and routine histology where rapid, reliable scanning is critical.

2Ocus 40
CategoryMicroscope Slide Scanner
Description

High-resolution digital microscope slide scanner at 40x magnification delivering exceptional clarity for cytology and other disciplines demanding precise image quality and detailed specimen examination.

3Ocus M Series
CategoryMicroscope Slide Scanner
Description

Multi-slide digital microscope scanner with four-slide capacity and innovative slide tray for extended scanning sessions. Supports both 20x and 40x magnification, designed for high-performance labs requiring reliable multi-slide scanning with minimal hands-on time.

4Visiopharm AI Software
CategoryAI Precision Pathology Software
Description

AI-driven precision pathology software providing nine IVDR-cleared diagnostic algorithms for automated image analysis, supporting cancer detection, tissue quantification, and biomarker analysis for diagnostic laboratories, biopharmaceutical research, and clinical applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

Grundium acquired Denmark-based Visiopharm, an AI-driven precision pathology software provider, to create an integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications. Visiopharm brings nine IVDR-cleared diagnostic algorithms and over 750 customer accounts. The acquisition builds on a pre-existing partnership between the two firms.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor for Grundium Ocus scanners in the United States, operating under Fisher Scientific brand. Manages local sales, customer relationships, and support for American customers.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor partner for Brazil market, providing sales and customer support services for Brazilian laboratories and healthcare institutions.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor partner for Turkey (Türkiye), with sales office in Istanbul providing regional sales and support for Turkish customers.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor partner for South Korea market, managing sales and customer support for Korean customers.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor partner for India market, operating as Sentier Healthcare, providing sales and support services for Indian customers.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor partner for Poland market, providing regional sales and customer support services.

8Bioanalytica
Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor partner for Greece market, managing sales and customer support for Greek customers.

grundium.com
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Implemented Grundium Ocus scanners for digital pathology workflows to improve rapid on-site evaluations (ROSE) and frozen section reviews. The partnership demonstrates application in major academic hospital settings with multi-location deployment.

Strategic tierNotableTypeStrategic or Co-development Partner
Description

Zoetis integrated Grundium Ocus®40 scanners into their VetScan Imagyst telepathology platform for veterinary diagnostics. Zoetis provides the Ocus scanners to independent clinics for AI-powered parasite detection and cytology reviews via remote pathologists.

Strategic tierNotableTypeTechnology or Integration
Description

Technology partner providing AI-powered digital diagnostic testing for Zoetis VetScan Imagyst platform. Techcyte's deep-learning AI algorithms analyze scanned images for automated parasite detection in veterinary samples.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hamamatsu's NanoZoomer series is the most widely deployed whole slide imaging scanner globally. Directly comparable to Grundium's Ocus line in target customer (pathology labs) and product category (microscope slide digitization), with broader installed base and FDA-cleared clinical use in the US.

TypeBroad incumbent
Description

Leica's Aperio GT 450 and AT2 scanners are entrenched enterprise WSI platforms integrated into Leica's broader histopathology portfolio (tissue processors, stains, microscopes). Competes with Grundium in mid-to-large hospital labs with bundled solutions and global service footprint.

TypeBroad incumbent
Description

Roche's digital pathology portfolio (Ventana DP200, navify Digital Pathology) competes with Grundium via integrated companion-diagnostic workflows. As a global diagnostics incumbent, Roche has unmatched enterprise sales reach and pulls WSI into companion diagnostic deals.

TypeBroad incumbent
Description

Philips IntelliSite Pathology Solution is an FDA-cleared WSI platform often paired with Philips PACS and clinical informatics. Competes with Grundium in large hospital networks seeking single-vendor enterprise imaging strategies.

TypeDirect peer
Description

Hungarian vendor of PANNORAMIC whole slide scanners and digital pathology software. Directly comparable compact and high-throughput scanners serving similar clinical and research pathology customers across Europe and globally.

TypeDirect peer
Description

Canadian maker of TissueScope whole slide scanners for clinical and research pathology. Closely comparable product positioning to Grundium's Ocus line, with similar emphasis on high-resolution imaging and remote workflows.

TypeDirect peer
Description

Motic's EasyScan and VM series compete with Grundium in affordable, compact WSI for clinical and educational pathology labs. Strong presence in Asia-Pacific and overlaps on price-sensitive mid-market segments.

TypeDirect peer
Description

US-based digital pathology vendor offering affordable WSI scanners and a cloud platform. Closely comparable to Grundium on positioning toward accessible, mid-market pathology digitization rather than enterprise tier-one deployments.

TypeDirect peer
Description

Indica Labs' HALO software platform is the closest direct competitor to Visiopharm's AI image analysis suite and now overlaps with Grundium's combined platform post-acquisition. Both target biopharma research and clinical pathology AI quantification workflows.

TypeEmerging player
Description

PathAI focuses on AI-powered pathology diagnostics and biopharma partnerships with proprietary algorithms. Partially overlaps with Visiopharm (now part of Grundium) in computational pathology AI for cancer detection and biomarker quantification.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Grundium

Digital Pathology Imaging Systemsgrundium.com

Grundium Oy is a Finnish medical technology company that develops the Ocus line of compact digital pathology slide scanners and, following its May 2026 Visiopharm acquisition, an integrated AI-powered precision pathology platform serving diagnostic laboratories, biopharma research, academic institutions, and veterinary clinics across 40+ countries.

What Grundium does

Grundium Oy is a Finnish medical technology company founded in 2015 in Tampere by former Nokia engineers, specializing in compact digital pathology microscope slide scanners marketed under the Ocus brand. The product line comprises the Ocus 20 (high-speed 20x scanning for intraoperative frozen sections), Ocus 40 (high-resolution 40x imaging for cytology and research), and the Ocus M Series (four-slide capacity for higher-volume labs). All scanners deliver browser-based access without additional software, support DICOM and SMB/HTTP export, and integrate with cloud platform services for remote consultation and telepathology workflows. The Ocus devices are CE-marked under the EU In Vitro Diagnostic Regulation (IVDR, EU 2017/746) for clinical/diagnostic use in Europe, while remaining classified as Research Use Only (RUO) in the United States.

In May 2026, Grundium acquired Denmark-based Visiopharm A/S, adding nine IVDR-cleared AI diagnostic algorithms and over 750 customer accounts across more than 40 countries, transforming the company from a hardware scanner vendor into an integrated precision pathology platform combining imaging hardware with AI-powered image analysis. The combined business serves diagnostic laboratories and hospitals, biopharmaceutical research and development organizations, academic and research institutions, and — through partnerships with Zoetis and Techcyte — the veterinary pathology vertical. Revenue mechanics mix one-time hardware sales of Ocus scanners with recurring cloud platform subscriptions and, post-Visiopharm, enterprise AI software subscriptions. Distribution combines direct enterprise field sales with a global distributor network including Fisher Healthcare (exclusive US distributor) and partners in Brazil, Turkey, Korea, India, Poland, and Greece. The company is privately held and backed by EW Healthcare Partners, a specialized healthcare investment firm.

Grundium firmographics

Firmographics
Name
Grundium
Legal name
Grundium Oy
Website
https://grundium.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
Grundium Oy is a Finnish medical technology company that develops the Ocus line of compact digital pathology slide scanners and, following its May 2026 Visiopharm acquisition, an integrated AI-powered precision pathology platform serving diagnostic laboratories, biopharma research, academic institutions, and veterinary clinics across 40+ countries.
Ownership category
akta.pro rank

Grundium industry classification

Industry
Product category
Digital Pathology Imaging Systems
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Digital pathology scanners
  • Microscope slide imaging
  • Whole slide imaging
  • Telepathology solutions
  • AI precision pathology

Where Grundium is headquartered

Location

Headquarters

HQ city
Tampere
HQ country
Finland
HQ region
Europe

Offices2 records

Markets served

Grundium business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Hardware Sales - Ocus Scanners: Sale of physical microscope slide scanner devices including Ocus 20, Ocus 40, and Ocus M Series. One-time capital purchase model for laboratory and clinical equipment.
  2. Cloud Platform & Software Subscriptions: Ongoing cloud connectivity and software platform services for scanner management, remote access, data storage, and team collaboration through grundium.net cloud infrastructure.
  3. Enterprise Platform Solutions (Post-Visiopharm): Integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications for diagnostic laboratories, biopharmaceutical development, and research organizations.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualQuote-based enterprise sales - no public pricing available

Go-to-market motion2 records

Distribution channels8 records

Marketing channels8 records

Grundium product offering

Product offering

Core offering

Grundium designs, manufactures, and sells the Ocus line of compact digital pathology microscope slide scanners (Ocus 20, Ocus 40, Ocus M Series) that convert glass slides into high-resolution whole-slide images accessible through any web browser. The company complements the hardware with a cloud platform for remote collaboration and, following the May 2026 acquisition of Visiopharm, AI-powered precision pathology image analysis software with nine IVDR-cleared diagnostic algorithms.

Product overview

Grundium offers the Ocus line of compact digital pathology microscope slide scanners, consisting of three scanner models: Ocus 20 (high-speed 20x scanning for frozen sections and routine histology), Ocus 40 (high-resolution 40x scanning for detailed cytology and research), and Ocus M Series (four-slide capacity multi-slide scanner for high-throughput labs). The scanners feature browser-based interfaces, onboard processing, and cloud connectivity through Grundium Cloud for remote access and collaboration. The product line recently expanded through the acquisition of Visiopharm, adding AI-powered precision pathology software with nine IVDR-cleared diagnostic algorithms for automated image analysis, creating an integrated end-to-end platform combining digital slide scanning with AI-powered diagnostic applications for diagnostic laboratories, biopharmaceutical research, and clinical applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Ocus®: Ocus® is Grundium's product line of microscope slide scanners for digital pathology, including Ocus® 20, Ocus® 40, and Ocus® M series models.
  • Ocus® 20
  • Ocus® 40
  • Ocus® M Series

Products and services

  • Ocus 20 High-speed digital microscope slide scanner optimized for 20x magnification, intended for time-sensitive procedures such as intraoperative frozen sections and routine histology where rapid, reliable scanning is critical.
  • Ocus 40 High-resolution digital microscope slide scanner at 40x magnification delivering exceptional clarity for cytology and other disciplines demanding precise image quality and detailed specimen examination.
  • Ocus M Series Multi-slide digital microscope scanner with four-slide capacity and innovative slide tray for extended scanning sessions. Supports both 20x and 40x magnification, designed for high-performance labs requiring reliable multi-slide scanning with minimal hands-on time.
  • Visiopharm AI Software AI-driven precision pathology software providing nine IVDR-cleared diagnostic algorithms for automated image analysis, supporting cancer detection, tissue quantification, and biomarker analysis for diagnostic laboratories, biopharmaceutical research, and clinical applications.

Quantifiable outcome

  • Reduced diagnostic turnaround time from days/weeks to minutes in veterinary telepathology applications
  • +3 more outcomes

Companies that use Grundium

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Grundium technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature11 records

Grundium partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, primary and notable.

  • VisiopharmcoreStrategic or Co-development Partner · 21 May 2026Grundium acquired Denmark-based Visiopharm, an AI-driven precision pathology software provider, to create an integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications. Visiopharm brings nine IVDR-cleared diagnostic algorithms and over 750 customer accounts. The acquisition builds on a pre-existing partnership between the two firms.
  • Fisher HealthcareprimaryChannel Partner/ Reseller/ DistributorExclusive distributor for Grundium Ocus scanners in the United States, operating under Fisher Scientific brand. Manages local sales, customer relationships, and support for American customers.
  • Biolab BrazilprimaryChannel Partner/ Reseller/ DistributorLocal distributor partner for Brazil market, providing sales and customer support services for Brazilian laboratories and healthcare institutions.
  • Neogen DiagnostikprimaryChannel Partner/ Reseller/ DistributorLocal distributor partner for Turkey (Türkiye), with sales office in Istanbul providing regional sales and support for Turkish customers.
  • SeongkohnprimaryChannel Partner/ Reseller/ DistributorLocal distributor partner for South Korea market, managing sales and customer support for Korean customers.
  • Sentier IndiaprimaryChannel Partner/ Reseller/ DistributorLocal distributor partner for India market, operating as Sentier Healthcare, providing sales and support services for Indian customers.
  • MarfourprimaryChannel Partner/ Reseller/ DistributorLocal distributor partner for Poland market, providing regional sales and customer support services.
  • BioanalyticaprimaryChannel Partner/ Reseller/ DistributorLocal distributor partner for Greece market, managing sales and customer support for Greek customers.
  • Washington University in St. LouisnotableStrategic or Co-development PartnerImplemented Grundium Ocus scanners for digital pathology workflows to improve rapid on-site evaluations (ROSE) and frozen section reviews. The partnership demonstrates application in major academic hospital settings with multi-location deployment.
  • Zoetis (VetScan Imagyst)notableStrategic or Co-development PartnerZoetis integrated Grundium Ocus®40 scanners into their VetScan Imagyst telepathology platform for veterinary diagnostics. Zoetis provides the Ocus scanners to independent clinics for AI-powered parasite detection and cytology reviews via remote pathologists.
  • TechcytenotableTechnology or IntegrationTechnology partner providing AI-powered digital diagnostic testing for Zoetis VetScan Imagyst platform. Techcyte's deep-learning AI algorithms analyze scanned images for automated parasite detection in veterinary samples.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Grundium competitors and assessment

Company assessment

Direct peers

  • Hamamatsu Photonics: Hamamatsu's NanoZoomer series is the most widely deployed whole slide imaging scanner globally. Directly comparable to Grundium's Ocus line in target customer (pathology labs) and product category (microscope slide digitization), with broader installed base and FDA-cleared clinical use in the US.
  • 3DHISTECH: Hungarian vendor of PANNORAMIC whole slide scanners and digital pathology software. Directly comparable compact and high-throughput scanners serving similar clinical and research pathology customers across Europe and globally.
  • Huron Digital Pathology: Canadian maker of TissueScope whole slide scanners for clinical and research pathology. Closely comparable product positioning to Grundium's Ocus line, with similar emphasis on high-resolution imaging and remote workflows.
  • Motic (Motic Digital Pathology): Motic's EasyScan and VM series compete with Grundium in affordable, compact WSI for clinical and educational pathology labs. Strong presence in Asia-Pacific and overlaps on price-sensitive mid-market segments.
  • OptraSCAN: US-based digital pathology vendor offering affordable WSI scanners and a cloud platform. Closely comparable to Grundium on positioning toward accessible, mid-market pathology digitization rather than enterprise tier-one deployments.
  • Indica Labs: Indica Labs' HALO software platform is the closest direct competitor to Visiopharm's AI image analysis suite and now overlaps with Grundium's combined platform post-acquisition. Both target biopharma research and clinical pathology AI quantification workflows.

Broad incumbents

  • Leica Biosystems (Danaher): Leica's Aperio GT 450 and AT2 scanners are entrenched enterprise WSI platforms integrated into Leica's broader histopathology portfolio (tissue processors, stains, microscopes). Competes with Grundium in mid-to-large hospital labs with bundled solutions and global service footprint.
  • Roche (Ventana): Roche's digital pathology portfolio (Ventana DP200, navify Digital Pathology) competes with Grundium via integrated companion-diagnostic workflows. As a global diagnostics incumbent, Roche has unmatched enterprise sales reach and pulls WSI into companion diagnostic deals.
  • Philips (IntelliSite): Philips IntelliSite Pathology Solution is an FDA-cleared WSI platform often paired with Philips PACS and clinical informatics. Competes with Grundium in large hospital networks seeking single-vendor enterprise imaging strategies.

Emerging players

  • PathAI: PathAI focuses on AI-powered pathology diagnostics and biopharma partnerships with proprietary algorithms. Partially overlaps with Visiopharm (now part of Grundium) in computational pathology AI for cancer detection and biomarker quantification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Grundium social profiles

Digital presence

Grundium compliance and trust

Trust signal

Compliance3 records

Grundium financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Grundium leadership team

Management profile

Number of profiles

Profiles4 records

Grundium subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Grundium funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Grundium M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grundium

What does Grundium do?

Grundium designs, manufactures, and sells the Ocus line of compact digital pathology microscope slide scanners (Ocus 20, Ocus 40, Ocus M Series) that convert glass slides into high-resolution whole-slide images accessible through any web browser. The company complements the hardware with a cloud platform for remote collaboration and, following the May 2026 acquisition of Visiopharm, AI-powered precision pathology image analysis software with nine IVDR-cleared diagnostic algorithms.

Is Grundium a public or private company?

Grundium is a private company. It is classified as venture growth investor backed and is currently operating.

When was Grundium founded?

Grundium was founded in 2015. It employs 51 to 100 people.

Where is Grundium based?

Grundium is headquartered in Tampere, Finland, in the Europe region.

How does Grundium make money?

Three revenue lines are on record. Hardware Sales - Ocus Scanners are the primary driver. The others are cloud Platform & Software Subscriptions and enterprise Platform Solutions (Post-Visiopharm).

Who are Grundium's main competitors?

Direct peers on record are Hamamatsu Photonics, 3DHISTECH, Huron Digital Pathology, Motic (Motic Digital Pathology), OptraSCAN and Indica Labs. Broad incumbents are Leica Biosystems (Danaher), Roche (Ventana) and Philips (IntelliSite). PathAI is listed as an emerging player.

Does Grundium have an API?

No public API is recorded for Grundium.

What industry is Grundium in?

Grundium's product category is Digital Pathology Imaging Systems. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Grundium Acquires AI Precision Pathology Software Provider VisiopharmGrundium, a Finland-based digital pathology scanner company backed by EW Healthcare Partners, has acquired Denmark-based Visiopharm, an AI-driven precision pathology software provider, to create an integrated precision pathology platform combining digital slide scanning with AI-powered diagnostic applications. The combined entity will serve diagnostic laboratories, biopharmaceutical development, and research organizations across more than 40 countries, with both companies continuing to support existing customers while offering integrated solutions over time. The acquisition is positioned as a transformational step in building a comprehensive digital and computational pathology platform targeting the growing precision diagnostics market, particularly in oncology.EU-StartupsFinland’s Grundium acquires Denmark’s Visiopharm to build an end-to-end AI precision pathology platformGrundium, a Tampere-based digital pathology imaging startup, has acquired Visiopharm, a Denmark-based provider of AI-driven precision pathology software, from an undisclosed seller. The combined entity integrates Grundium's compact scanner portfolio with Visiopharm's AI-powered image analysis tools and nine IVDR-cleared diagnostic algorithms to create an end-to-end platform for diagnostic laboratories, biopharmaceutical research, and clinical applications. Both companies will continue supporting their existing products independently while offering customers the option to combine capabilities, and the acquisition builds on a pre-existing integration partnership between the two firms.BebeezFinland’s Grundium acquires Denmark’s Visiopharm to build an end-to-end AI precision pathology platform – BeBeez InternationalGrundium, a Tampere-based digital pathology startup backed by EW Healthcare Partners, has acquired Denmark's Visiopharm, a provider of AI-driven precision pathology software, in a deal that combines complementary imaging and AI capabilities into a single end-to-end platform. The merged entity aims to serve diagnostic laboratories, biopharmaceutical developers, and researchers with a broader range of digital pathology solutions spanning individual lab workflows to enterprise-scale deployments. The acquisition strengthens a prior partnership between the two companies, with both product lines continuing to be supported independently while enabling customers to combine capabilities as needed.VisiopharmGrundium acquires Visiopharm to create integrated precision pathology platformGrundium acquired Visiopharm to combine digital slide scanning with AI-driven precision pathology software. The combined platform targets diagnostic laboratories, biopharmaceutical development, and research, with existing customers able to continue using either product independently.Irw-PressGrundium Acquires Visiopharm to Create Integrated Precision Pathology PlatformGrundium Oy, a Finnish digital pathology scanner company backed by EW Healthcare Partners, has acquired Visiopharm A/S, a Danish AI-driven precision pathology software company, to create an integrated end-to-end platform for diagnostic laboratories and biopharmaceutical research. The combined entity brings together Grundium's imaging technology with Visiopharm's nine IVDR-cleared diagnostic algorithms and over 750 customer accounts across 40 countries. The acquisition builds on an existing partnership and is described by EW Healthcare Partners as a transformational step toward building a comprehensive digital and computational pathology platform.news.cision.comVirtual pathology streamlines rapid on-site evaluation (ROSE) and frozen sections for major multi-site academic hospitalWashington University in St. Louis has implemented Grundium's Ocus® digital slide scanners across six locations to perform rapid on-site evaluations (ROSE) and frozen sections, replacing hours of daily pathologist travel and waiting time with active case review. The university reported saving the equivalent of an additional workday of diagnostic productivity each week while maintaining diagnostic accuracy comparable to traditional methods. The digital pathology approach also reduced repeat biopsies, lowered patient costs and anxiety, and enabled real-time preliminary diagnoses while patients remained sedated.AllpcbAI Frameworks for Medical Device Prediction: Case StudiesThe article examines the application of Edge AI frameworks, specifically alwaysAI and Roboflow, to enhance medical device prediction and digital pathology diagnostics. It highlights how these technologies enable real-time patient monitoring and automated analysis of high-resolution whole-slide images to improve diagnostic efficiency. Specific case studies include Grundium Ltd's integration of NVIDIA Jetson platforms for whole-slide imaging and the development of portable AI-powered brain CT scanners.GlobeNewswireEW Healthcare Partners Announces the Acquisition of a Majority Stake in Grundium OYEW Healthcare Partners acquired a majority stake in Grundium Oy, a Finnish digital pathology scanner company. The founders and management will retain a significant minority stake and remain in leadership positions. The partnership aims to support Grundium's expansion into new applications and geographies, particularly in the U.S.GlobeNewswireEW Healthcare Partners Announces the Acquisition of a Majority Stake in Grundium OYEW Healthcare Partners has acquired a majority stake in Grundium Oy, a Finnish company specializing in advanced imaging technology and digital pathology scanners. The transaction allows Grundium to expand its international presence, particularly into the U.S. market, while its founders retain a minority stake and remain in leadership roles.